Sarah Connor Lassey, M.D.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Placenta Previa | 1 | 2023 | 117 | 0.830 |
Why?
|
| Oxytocics | 1 | 2021 | 68 | 0.750 |
Why?
|
| Labor Stage, Second | 1 | 2020 | 31 | 0.730 |
Why?
|
| Placenta Accreta | 1 | 2023 | 225 | 0.720 |
Why?
|
| Labor, Induced | 1 | 2021 | 146 | 0.710 |
Why?
|
| Cesarean Section | 4 | 2023 | 1363 | 0.710 |
Why?
|
| Home Childbirth | 1 | 2019 | 50 | 0.670 |
Why?
|
| Obstetric Labor Complications | 2 | 2019 | 238 | 0.620 |
Why?
|
| Trial of Labor | 1 | 2018 | 80 | 0.610 |
Why?
|
| Vaginal Birth after Cesarean | 1 | 2018 | 62 | 0.600 |
Why?
|
| Perinatal Care | 1 | 2019 | 227 | 0.590 |
Why?
|
| Oxytocin | 1 | 2021 | 395 | 0.580 |
Why?
|
| Hyperemesis Gravidarum | 1 | 2016 | 23 | 0.570 |
Why?
|
| Rehydration Solutions | 1 | 2016 | 47 | 0.560 |
Why?
|
| Hyponatremia | 1 | 2019 | 298 | 0.560 |
Why?
|
| Catheterization | 1 | 2021 | 1468 | 0.530 |
Why?
|
| Water-Electrolyte Imbalance | 1 | 2016 | 113 | 0.520 |
Why?
|
| Rhabdomyolysis | 1 | 2016 | 150 | 0.510 |
Why?
|
| Parity | 1 | 2018 | 929 | 0.490 |
Why?
|
| Labor, Obstetric | 1 | 2018 | 333 | 0.490 |
Why?
|
| Aneuploidy | 1 | 2017 | 530 | 0.460 |
Why?
|
| Patient Transfer | 1 | 2019 | 760 | 0.420 |
Why?
|
| Fluid Therapy | 1 | 2016 | 592 | 0.420 |
Why?
|
| Abortion, Induced | 1 | 2017 | 458 | 0.390 |
Why?
|
| Pregnancy | 11 | 2023 | 29087 | 0.310 |
Why?
|
| Cervical Ripening | 1 | 2021 | 18 | 0.200 |
Why?
|
| Cystadenocarcinoma, Serous | 1 | 2015 | 450 | 0.200 |
Why?
|
| Thrombelastography | 1 | 2023 | 163 | 0.200 |
Why?
|
| Pregnancy in Diabetics | 1 | 2021 | 179 | 0.170 |
Why?
|
| Cerclage, Cervical | 1 | 2020 | 39 | 0.170 |
Why?
|
| Catheters | 1 | 2021 | 422 | 0.150 |
Why?
|
| Uterine Rupture | 1 | 2018 | 72 | 0.150 |
Why?
|
| Uterine Hemorrhage | 1 | 2018 | 255 | 0.140 |
Why?
|
| Cervix Uteri | 1 | 2020 | 591 | 0.130 |
Why?
|
| Uterine Neoplasms | 1 | 2015 | 1513 | 0.130 |
Why?
|
| Endometrial Neoplasms | 1 | 2015 | 1351 | 0.130 |
Why?
|
| Hypokalemia | 1 | 2016 | 153 | 0.130 |
Why?
|
| Dehydration | 1 | 2016 | 230 | 0.120 |
Why?
|
| Pregnancy Outcome | 2 | 2021 | 2795 | 0.110 |
Why?
|
| Combined Modality Therapy | 2 | 2021 | 8621 | 0.110 |
Why?
|
| Prenatal Care | 1 | 2020 | 1088 | 0.110 |
Why?
|
| Decision Support Techniques | 1 | 2023 | 1952 | 0.110 |
Why?
|
| Female | 12 | 2023 | 379592 | 0.100 |
Why?
|
| Adult | 8 | 2021 | 213712 | 0.100 |
Why?
|
| Diabetes, Gestational | 1 | 2021 | 1184 | 0.100 |
Why?
|
| Multivariate Analysis | 2 | 2018 | 12242 | 0.090 |
Why?
|
| Young Adult | 3 | 2021 | 56350 | 0.080 |
Why?
|
| Gestational Age | 1 | 2017 | 3490 | 0.080 |
Why?
|
| Boston | 2 | 2019 | 9305 | 0.080 |
Why?
|
| Laparoscopy | 1 | 2020 | 2121 | 0.080 |
Why?
|
| Economics, Medical | 1 | 2008 | 113 | 0.080 |
Why?
|
| Time Factors | 2 | 2021 | 40054 | 0.080 |
Why?
|
| Humans | 13 | 2023 | 742088 | 0.070 |
Why?
|
| Proportional Hazards Models | 1 | 2021 | 12344 | 0.070 |
Why?
|
| Double-Blind Method | 1 | 2020 | 12017 | 0.070 |
Why?
|
| Pregnancy Complications | 1 | 2019 | 2861 | 0.060 |
Why?
|
| Prostatic Neoplasms | 1 | 2008 | 11039 | 0.060 |
Why?
|
| Treatment Outcome | 3 | 2020 | 62966 | 0.060 |
Why?
|
| Diagnosis, Differential | 1 | 2019 | 12958 | 0.060 |
Why?
|
| Logistic Models | 1 | 2018 | 13403 | 0.050 |
Why?
|
| Adolescent | 2 | 2021 | 85649 | 0.050 |
Why?
|
| Medically Uninsured | 1 | 2008 | 852 | 0.050 |
Why?
|
| Retrospective Studies | 3 | 2021 | 77098 | 0.050 |
Why?
|
| Extraction, Obstetrical | 1 | 2020 | 26 | 0.050 |
Why?
|
| SEER Program | 1 | 2015 | 1507 | 0.050 |
Why?
|
| Comorbidity | 2 | 2019 | 10372 | 0.040 |
Why?
|
| Prospective Studies | 2 | 2021 | 53187 | 0.040 |
Why?
|
| Middle Aged | 3 | 2021 | 213127 | 0.040 |
Why?
|
| Pregnancy Trimester, Second | 1 | 2020 | 732 | 0.040 |
Why?
|
| Risk Factors | 1 | 2023 | 72145 | 0.040 |
Why?
|
| Poverty | 1 | 2008 | 2646 | 0.030 |
Why?
|
| Recurrence | 1 | 2008 | 8333 | 0.030 |
Why?
|
| Emotions | 1 | 2008 | 2657 | 0.030 |
Why?
|
| Pregnancy Trimester, First | 1 | 2020 | 851 | 0.030 |
Why?
|
| Odds Ratio | 1 | 2008 | 9846 | 0.030 |
Why?
|
| Delivery, Obstetric | 1 | 2019 | 904 | 0.030 |
Why?
|
| Placenta | 1 | 2021 | 1694 | 0.030 |
Why?
|
| Survival Rate | 1 | 2015 | 12773 | 0.020 |
Why?
|
| Neoplasm Staging | 1 | 2015 | 11001 | 0.020 |
Why?
|
| Medicare | 1 | 2015 | 6532 | 0.020 |
Why?
|
| Quality of Life | 1 | 2008 | 12730 | 0.020 |
Why?
|
| Insulin | 1 | 2021 | 6575 | 0.020 |
Why?
|
| Prognosis | 1 | 2015 | 29010 | 0.020 |
Why?
|
| Antineoplastic Combined Chemotherapy Protocols | 1 | 2015 | 11472 | 0.020 |
Why?
|
| Aged | 2 | 2015 | 162944 | 0.020 |
Why?
|
| Follow-Up Studies | 1 | 2015 | 39004 | 0.010 |
Why?
|
| Severity of Illness Index | 1 | 2019 | 15530 | 0.010 |
Why?
|
| Infant, Newborn | 1 | 2021 | 25575 | 0.010 |
Why?
|
| Risk Assessment | 1 | 2019 | 23320 | 0.010 |
Why?
|
| United States | 1 | 2015 | 69693 | 0.010 |
Why?
|
| Male | 1 | 2008 | 349538 | 0.010 |
Why?
|